Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

Jun 19, 2020

SELL
$5.79 - $11.78 $91,435 - $186,029
-15,792 Closed
0 $0
Q4 2019

Jan 31, 2020

SELL
$9.47 - $16.71 $418,649 - $738,715
-44,208 Reduced 73.68%
15,792 $168,000
Q3 2017

Oct 25, 2017

BUY
$11.94 - $14.29 $716,400 - $857,400
60,000
60,000 $734,000

Others Institutions Holding CELC

About Celcuity Inc.


  • Ticker CELC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,941,300
  • Market Cap $208M
  • Description
  • Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...
More about CELC
Track This Portfolio

Track State Of New Jersey Common Pension Fund D Portfolio

Follow State Of New Jersey Common Pension Fund D and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of New Jersey Common Pension Fund D, based on Form 13F filings with the SEC.

News

Stay updated on State Of New Jersey Common Pension Fund D with notifications on news.